European Journal of Hospital Pharmacy

Papers
(The TQCC of European Journal of Hospital Pharmacy is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Stability of dexmedetomidine, ketamine and lidocaine combined injectable solution for analgesia57
Evaluation of inappropriate antibiotic prescribing and management through pharmacist-led antimicrobial stewardship programmes: a meta-analysis of evidence46
Improve quality of care in hospital-at-home by implementing medication reconciliation on admission: a retrospective observational study41
Potential therapeutic effects of different mouthwashes for alleviation and treatment of oral complications of 5-fluorouracil-based chemotherapy in patients with colon cancer35
Development of a 50% (w/v) aluminium chloride hexahydrate solution as haemostatic agent21
The environmental impact of inhalers: a framework for sustainable prescription practices in Spain20
Using machine learning or deep learning models in a hospital setting to detect inappropriate prescriptions: a systematic review18
Spain takes over Presidency of the Council of the European Union13
Automated unit dose dispensing systems producing individually packaged and labelled drugs for inpatients: a systematic review13
Medicines Delivery Proximity Programme (PEMProxi) survey results12
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain11
Optimising adalimumab administration to improve patient experience and treatment adherence in immune-mediated inflammatory diseases10
Medication stability: from pharmacies to patients’ homes—is consistent storage achievable?10
Retrospective study of patient characteristics and treatment for mucormycosis in post COVID-19 population in a tertiary care hospital10
Comparison of pharmacokinetics software for therapeutic drug monitoring of piperacillin in patients with severe infections10
Automated preparation of cytotoxic drugs: the evidence for an interface between the robot and computerized provider order entry?10
Reducing the use of sleep-inducing drugs during hospitalisation by a multi-faceted intervention: a pilot study10
Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients8
Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing8
Investigating the capabilities of advanced large language models in generating patient instructions and patient educational material8
Costs, challenges and opportunities of decentralised chimeric antigen receptor T-cell production: a literature review and clinical experts’ interviews8
Stability assessment and content determination test of oral liquid forms of beclomethasone dipropionate prepared in hospital pharmacy8
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations7
Conflict of interest declarations in published healthcare reports and the need for supportive legislative frameworks: focus on hospital pharmacists' research activity worldwide7
Clinical pharmacy interventions in an Austrian hospital: a report highlights the need for the implementation of clinical pharmacy services7
Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients6
Medication reconciliationis it possible to speed up without compromising quality? A before–after study in the emergency department6
Successful desensitisation to paclitaxel with omalizumab6
Automation of parenteral nutrition: impact on process and cost analysis6
Advanced therapy medicinal products6
Capecitabine: guaranteed access in adjuvant treatment of breast cancer6
Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease6
Impact of the use of a drug–drug interaction checker on pharmacist interventions involving well-known strong interactors5
Container closure integrity testing and process validation of closed system transfer devices for aseptic reconstitution of drug vials connected to fluid bags5
Clinical pharmacy as a guarantee of safety in times of crisis: evolution and relevance of the continued presence of clinical pharmacists in frontline medical units during the first wave of COVID-195
Analysis of adverse drug events as a way to improve cancer patient care5
Potential impact of national recommendations to use short course antibiotic therapy on antibiotic use in the emergency department of a UK hospital: retrospective observational study5
In-hospital expenditure for medical devices in relation to funds from diagnosis-related groups and ambulatory activity: temporal trend from 2019 to 20225
Evaluation of the appropriateness of vancomycin therapeutic drug monitoring in the intensive care unit with a clinical pharmacy approach, a cross-sectional study5
Harm to a child caused by the off-label use of prochlorperazine maleate tablets due to the discontinuation of licensed prochlorperazine mesilate liquid in the UK5
Factors influencing accuracy when preparing injectable drug concentrations in appliance with clinical practice: a norepinephrine case study5
Optimised quality control method for determination of the radiochemical purity of [99mTc]Tc-mebrofenin and [99mTc]Tc-etifenin in a clinical context5
Investigation of the hospital pharmacy profession in Europe5
How can oral second-line anti-tuberculosis medications be administered to an extremely preterm neonate?5
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years4
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series4
Testing of parenteral drug products for visible particles: comparison of the Ph. Eur. method with an alternative method using polarised light4
Medication-related problems in critical care survivors: a systematic review4
Using Healthcare Failure Mode and Effect Analysis in prospective medication safety risk management in secondary care inpatient wards4
Performance evaluation of the HPLC diode array and evaporative light scattering detection for the implementation of dose-banded gemcitabine infusion bags4
Anticholinergic burden and revisit risk in frail patients with pharmacological sleepiness4
Development and implementation of medication-related clinical rules for obstetrics, gynaecology, and paediatric outpatients4
Performance and risks of ChatGPT used in drug information: comment4
EAHP sets out to future-proof the hospital pharmacy workforce4
Increasing the number of pharmacist-led medication order reviews using the available workforce: a retrospective study4
Medicine shortages in France: a 6-year retrospective study in a university medical centre4
Factors affecting voriconazole concentration to dose ratio changes according to route of administration4
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document4
Evolution of hospital clinical pharmacy services in Finland in the period 2017–2022: the third nationwide follow-up survey4
Game-based training to promote handwashing, handrub and gloving for hospital pharmacy operators4
Medical device resources for hospital pharmacists4
Impact of implementing the aseptic compounding management system, Medcura, on internal error rates within an oncology pharmacy aseptic unit: a mixed methods evaluation4
Stability of clozapine tablets repackaged in dose administration aids using repackaging machines3
Tezacaftor-ivacaftor use in routine care of adults with cystic fibrosis: a medicine use evaluation3
Experience in managing independent clinical research, the best training strategy for future clinical pharmacists: the QOSMOS project3
COVID-19 impact on skills and professional perceptions of the hospital pharmacist during the first outbreak wave3
Epileptic convulsions probably induced by desloratadine: a case report3
Analytical and clinical validation of an LC-MS/MS method for carbamazepine, lamotrigine and levetiracetam in dried blood spots3
COP27 climate change conference: urgent action needed for Africa and the world3
SARS-CoV-2: an opportunity for hospital pharmacy3
EAHP’s new President András Süle starts his term together with eight newly elected Board members3
The CLEO assessment tool for pharmacist interventions3
Infectious diseases and antimicrobial resistance3
Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings3
Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials3
The European coalition for vaccination calls on healthcare professionals to get vaccinated against COVID-193
EAHP’s needs assessment survey3
Successful treatment of Verona integron-encoded metallo-β-lactamase-producingKlebsiella pneumoniaeinfection using the combination of ceftazidime/avibactam and aztreonam3
Real-world outcomes of abiraterone and enzalutamide in first-line treatment of metastatic castration-resistant prostate cancer: which patients benefit most?3
Biological therapy for ocular Behçet’s disease with off-label drug prescription in Turkey3
Advanced ALK-positive lung cancer with lorlatinib versus crizotinib in Asian patients with brain metastases3
A pharmacovigilance study on antiepileptic medications in a paediatric hospital in Italy3
Antifungal drug resistance: an update3
Investigation on the knowledge level of the rational application of antimicrobial drugs among pharmacists in medical institutions in Shanxi Province3
Frequency of paediatric patients administered extemporaneous preparations at a Swedish university hospital: a registry-based study comparing two study-years, 10 years apart2
Keeping the focus on antimicrobials2
Combination of a propofol emulsion with alpha-2 adrenergic receptor agonists used for multimodal analgesia or sedation in intensive care units: a physicochemical stability study2
Hospital pharmacists’ first impressions on the revision of the General Pharmaceutical Legislation2
Design and validation of a predictive equation to estimate unbound valproic acid concentration2
Liquid antimicrobials: a national analysis of critical shortages2
Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors2
Rosuvastatin-induced rhabdomyolysis: case report and call for proactive multifactorial risk assessment and preventive management of statin therapy in high-risk patients2
Improvement in RAID questionnaire results in patients with rheumatoid arthritis treated with advanced therapies2
Oncostability: stability of reconstituted and diluted anticancer medicines for a possible extension of use2
EAHP-EANM joint statement2
Clinical frailty and polypharmacy in older emergency critical care patients: a single-centre retrospective case series2
Real-world evidence: what is it and can it be trusted?2
Drugs associated with tachyphylaxis: results from a retrospective pharmacovigilance study using disproportionality analysis2
Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection2
EAHP general assembly updates position paper on clinical trials2
Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-192
Optimising electronic health records for highly specialised hospital areas: a call for collaborative hospital pharmacist involvement2
Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS Yellow Cover Document standards2
Antimicrobial resistance: a major priority for global focus2
Does the use of new cephalosporins follow the authorised, financed and approved indications? A study of their use in routine clinical practice in a tertiary hospital2
Empowering European hospital pharmacists in the face of heart failure2
Optimisation of the quality of care for patients with severe asthma: ASfarMA project2
The threatened medicines information pharmacist!2
Introduction to an online only issue2
Risk factors for early onset acute kidney injury after allogeneic haematopoietic stem cell transplantation and the role of drug–drug interactions2
Levetiracetam pharmacokinetics and its covariates: proposal for optimal dosing in the paediatric population2
Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations2
Assessing health outcomes: a systematic review of electronic patient-reported outcomes in oncology2
Rational use of metaraminol can improve pharmaceutical care2
Results of EAHP’s 2023 shortages survey2
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn’s disease: an interview study2
Over 40% of cancer patients use complementary and alternative medications while receiving anticancer treatment2
Hospital pharmacy response to COVID-19 at two UK teaching hospitals: a departmental review of actions implemented to inform future strategy2
Clinical pharmacists’ services, role and acceptance: a national Swedish survey2
Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital setting2
Accuracy of an electronic prescribing system for standard treatments2
Impact of a pharmaceutical intervention on influenza vaccination in patients receiving treatment with biological medicines2
Qualification and impact of a video-assisted control system in a chemotherapy compounding unit2
Roberto Frontini appointed as a member of PRAC2
Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients2
Addressing the at-home care needs of patients with multidrug-resistant bacteria: what should we do?2
Evaluation of drug interaction between cyclosporine and lercanidipine: a descriptive study2
Can antibiotics affect the clinical features of patients with candidemia? The retrospective evaluation of 5 years of data in an intensive care unit2
Prevalence of compliance with PIMDINAC criteria among elderly people living with HIV and in non-infected outpatients with other chronic diseases2
Effectiveness of a low trough serum concentration of vancomycin on acute kidney injury in infants and toddlers in the paediatric intensive care unit2
Haemodynamic effects of intravenous acetaminophen in critically ill paediatric patients: a retrospective chart review2
Interprofessional collaborative practice is strong in young health professionals: evidence from an Italian Winter School attended by hospital pharmacists and internal medicine physicians2
Rare complication of doxorubicin-induced complete heart block in a patient with Hodgkin’s lymphoma: a case report2
Quantifying the effect of in-hospital antimicrobial use on the development of colistin-resistantAcinetobacter baumanniistrains: a time series analysis2
Implementation and effectiveness of pharmacist-led interviews at patient hospital admission in a rheumatology department2
Evaluation of the impact of the addition of a heart failure prescribing pharmacist to consultant-led heart failure ward round at a tertiary hospital2
EMA/HMA joint statement on the scientific rationale supporting interchangeability of biosimilar medicines in the EU2
Spread awareness, stop resistance – getting ready for WAAW and EAAD2
Stability of intravenous medicines – evidence of maximum temperature reached in both summer and winter within soft shell elastomeric pumps2
Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-192
EJHP’s impact factor moves on up2
0.072459936141968